Hub Group Inc. (HUBG)
NASDAQ: HUBG
· Real-Time Price · USD
32.94
0.16 (0.49%)
At close: Jun 20, 2025, 3:59 PM
32.94
0.00%
After-hours: Jun 20, 2025, 06:07 PM EDT
0.49% (1D)
Bid | 32.5 |
Market Cap | 2B |
Revenue (ttm) | 3.86B |
Net Income (ttm) | 103.79M |
EPS (ttm) | 1.7 |
PE Ratio (ttm) | 19.38 |
Forward PE | 13.43 |
Analyst | Hold |
Ask | 34.51 |
Volume | 316,160 |
Avg. Volume (20D) | 613,282 |
Open | 33.09 |
Previous Close | 32.78 |
Day's Range | 32.70 - 33.17 |
52-Week Range | 30.75 - 53.21 |
Beta | 1.15 |
About HUBG
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol HUBG
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for HUBG stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Hub Group Inc. is scheduled to release its earnings on Jul 31, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
-4.62%
Shares of companies within the broader industrial ...
Unlock content with
Pro Subscription
4 months ago
-4.23%
Hub Group shares are trading lower after the company reported Q4 revenue below estimates.

3 weeks ago · newsfilecorp.com
Defence Therapeutics Opens U.S. Laboratory in Boston-Cambridge Biotech HubMontreal, Quebec--(Newsfile Corp. - June 2, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a leading biotechnology company specializing in advanc...